MCA-F-501/07, version 2 – 24 February 2025
Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.
MCA-F-501/07, version 2 – 24 February 2025 is the official MCA identifier for “Clinical Trial Progress Report”. MCA-F-501/07, version 2 – 24 February 2025 is the official identifier MCA uses for this instrument.
- Instrument
- MCA-F-501
- Full name
- MCA-F-501/07, version 2 – 24 February 2025
- Category
- Clinical Trials
- Source publication
- English
- Readable HTML
- 1 language version
- Published
- —
- Effective
- —
Open a language version
Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
Clinical Trial Progress Report
Complete four-page clinical trial progress report, version 2 dated 24 February 2025. It records study and site progress, participants, adverse events, trial changes, amendments and protocol or GCP deviations. It states that added trial sites should be submitted as an amendment and contains a conditional ethics-opinion review note; neither is a general device marketing variation rule or market-processing deadline. Both printed SECTION G headings are retained. Later revisions and current applicability remain unverified.
MCA-F-501/07, version 2 – 24 February 2025 is the official identifier MCA uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.